2014
DOI: 10.5009/gnl13130
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcome after Endoscopic Submucosal Dissection in Patients with Superficial Esophageal Squamous Cell Carcinoma: A Single-Center Study

Abstract: Background/AimsSuperficial esophageal squamous cell carcinoma (SESCC) is being increasingly detected during screening endoscopy. Endoscopic submucosal dissection (ESD) allows for en bloc and histologically complete resection of lesions. This study assessed the technical feasibility and long-term outcomes of ESD for SESCCs.MethodsBetween January 2005 and August 2012, 27 patients with 28 SESCCs underwent ESD at Pusan National University Hospital. The en bloc and pathologically complete resection rates, complicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
33
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(40 citation statements)
references
References 24 publications
6
33
1
Order By: Relevance
“…However, complete resection rate seemed to be lower than previously reported studies, where rates varied between 80 and 94.6% [14, 17, 20, 21]. There may be at least 1 main explanation for such a rate.…”
Section: Discussioncontrasting
confidence: 64%
“…However, complete resection rate seemed to be lower than previously reported studies, where rates varied between 80 and 94.6% [14, 17, 20, 21]. There may be at least 1 main explanation for such a rate.…”
Section: Discussioncontrasting
confidence: 64%
“…Our results suggest that HNSCC background does not adversely affect the clinical outcome of patients with superficial ESCC managed by ESD. OS and complication rates were similar between the two groups and consistent with findings from previous studies [9,17,18,[20][21][22][23][24][25][26][27][28][29][30][31].…”
Section: Discussionsupporting
confidence: 91%
“…Additional surgical resection cases with residual tumors after ESD, and non-additional resection cases with recurrence after ESD. However, previous studies described the safety of ESD; and the indication for ESD has gradually been expanded to larger and deeper tumors (1,2,10,11). In Japan, EC has been approved as an indication for ESD under health insurance coverage since 2008.…”
Section: Discussionmentioning
confidence: 99%